Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bruker (BRKRP) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to 6.02%.

  • Bruker's EBIT Margin fell 139000.0% to 6.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.83%, marking a year-over-year decrease of 69500.0%. This contributed to the annual value of 7.39% for FY2024, which is 73500.0% down from last year.
  • Per Bruker's latest filing, its EBIT Margin stood at 6.02% for Q3 2025, which was down 139000.0% from 1.49% recorded in Q2 2025.
  • Bruker's 5-year EBIT Margin high stood at 20.55% for Q3 2022, and its period low was 6.02% during Q3 2025.
  • Moreover, its 5-year median value for EBIT Margin was 12.64% (2023), whereas its average is 11.81%.
  • As far as peak fluctuations go, Bruker's EBIT Margin surged by 121900bps in 2021, and later crashed by -139000bps in 2025.
  • Bruker's EBIT Margin (Quarter) stood at 18.35% in 2021, then increased by 1bps to 18.49% in 2022, then plummeted by -35bps to 12.11% in 2023, then plummeted by -43bps to 6.94% in 2024, then plummeted by -187bps to 6.02% in 2025.
  • Its EBIT Margin stands at 6.02% for Q3 2025, versus 1.49% for Q2 2025 and 3.97% for Q1 2025.